Elevance Health stock reaches 52-week high

uk.investing.com

Elevance Health stock reached a 52-week high of $427.49, reflecting strong year-to-date and annual returns. The company's stock has seen a 19.91% return year-to-date and a 23.23% increase over the past year, with analysts suggesting further upside potential. Elevance Health is expected to report earnings on July 15, with analysts providing varied outlooks on its performance and Medicaid enrollment.


With a significance score of 1, this news ranks in the top 62% of today's 31310 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Elevance Health stock reaches 52-week high | News Minimalist